L
33.11
-0.72 (-2.13%)
| 前收盘价格 | 33.83 |
| 收盘价格 | 34.09 |
| 成交量 | 1,718,277 |
| 平均成交量 (3个月) | 1,297,062 |
| 市值 | 6,111,145,984 |
| 预期市盈率 (P/E Forward) | 21.74 |
| 价格/销量 (P/S) | 8.32 |
| 股市价格/股市净资产 (P/B) | 6.43 |
| 52周波幅 | |
| 利润日期 | 11 Nov 2025 |
| 营业毛利率 | -29.95% |
| 营业利益率 (TTM) | -25.97% |
| 稀释每股收益 (EPS TTM) | -1.18 |
| 季度收入增长率 (YOY) | 107.50% |
| 总债务/股东权益 (D/E MRQ) | 35.65% |
| 流动比率 (MRQ) | 5.20 |
| 营业现金流 (OCF TTM) | -263.30 M |
| 杠杆自由现金流 (LFCF TTM) | -202.32 M |
| 资产报酬率 (ROA TTM) | -8.77% |
| 股东权益报酬率 (ROE TTM) | -20.00% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | Legend Biotech Corporation | 看涨 | 混合的 |
AIStockmoo 评分
0.5
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | 1.0 |
| 技术平均移动指标 | -1.5 |
| 技术振荡指标 | -2.5 |
| 平均 | 0.50 |
|
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 1.31% |
| 机构持股比例 | 47.92% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Hhlr Advisors, Ltd. | 30 Jun 2025 | 5,984,550 |
| Deerfield Management Company, L.P. | 30 Jun 2025 | 2,962,338 |
| Braidwell Lp | 30 Jun 2025 | 2,542,104 |
| Matthews International Capital Management Llc | 30 Jun 2025 | 1,293,052 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 83.00 (Morgan Stanley, 150.68%) | 购买 |
| 中 | 76.00 (129.54%) | |
| 低 | 54.00 (UBS, 63.09%) | 购买 |
| 平均值 | 72.17 (117.97%) | |
| 总计 | 6 购买 | |
| 平均价格@调整类型 | 36.89 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Cantor Fitzgerald | 27 Aug 2025 | 66.00 (99.34%) | 购买 | 34.72 |
| JP Morgan | 25 Aug 2025 | 78.00 (135.58%) | 购买 | 34.60 |
| Morgan Stanley | 12 Aug 2025 | 83.00 (150.68%) | 购买 | 36.99 |
| 10 Jul 2025 | 81.00 (144.64%) | 购买 | 39.71 | |
| RBC Capital | 12 Aug 2025 | 77.00 (132.56%) | 购买 | 36.99 |
| HC Wainwright & Co. | 17 Jul 2025 | 75.00 (126.52%) | 购买 | 42.13 |
| 08 Jul 2025 | 75.00 (126.52%) | 购买 | 37.49 | |
| UBS | 02 Jul 2025 | 54.00 (63.09%) | 购买 | 35.91 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合